Valneva rises on vaccines distribution deal in Germany

Bavarian Nordic A/S

26/06/2025 08:34

** Shares in Valneva VLS.PA rise around 3% after the French vaccine maker entered an exclusive marketing and distribution agreement with Germany's CSL Seqirus

** Under the agreement CSL will start commercialisation of Valneva's three vaccines in Germany

** BNP Paribas' Portzamparc analyst says the agreement solves the problem of a previous collaboration with Bavarian Nordic BAVA.CO, which has become its direct rival in the chikungunya vaccine market

** The company also confirmed its guidance for full-year product sales growth to between 170-180 million euro

** Up to the previous session's close, shares were up 8.6%​ YTD

 (Reporting by Mateusz Rabiega)

 ((Mateusz.rabiega@thomsonreuters.com;))